Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS7 | Q9UKP4 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24927849 | 0.79 | ADAMTS7 (0.53) | ADAMTS7 | |
| SCHEMBL23354086 | 0.77 | ADAMTS7 (0.56) | ADAMTS7 | |
| SCHEMBL23371329 | 0.72 | ADAMTS7 (0.44) | ADAMTS7 | |
| Hydrochloric Acid SCHEMBL23354184 | 0.71 | ADAMTS7 (0.43) | ADAMTS7 | |
| SCHEMBL23354364 | 0.67 | ADAMTS7 (0.50) | ADAMTS7 | |
| SCHEMBL24927820 | 0.66 | ADAMTS7 (0.41) | ADAMTS7 | |
| SCHEMBL23361479 | 0.65 | ADAMTS7 (0.55) | ADAMTS7 | |
| SCHEMBL23354019 | 0.62 | ADAMTS7 (0.43) | ADAMTS7 | |
| SCHEMBL24927869 | 0.60 | ADAMTS7 (0.43) | ADAMTS7 | |
| SCHEMBL24927992 | 0.59 | ADAMTS7 (0.33) | ADAMTS7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230027985-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027985-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | ADAMTS7, MMP7, ADAMTS1 | ADAMTS7 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.